They also revealed that the trend for reduction in the number of surviving tumour cells during all schedules of radiotherapy was pronounced in the case of the tumour with wild type p53, which was more radiosensitive compared with the tumour with mutant p53. This evidence concerns the gene TP53 and neoplasm.